Prospective ‘real world’ registry for the use of the ‘PCB only’ strategy in small vessel de novo lesions

Abstract

To date, this is the largest prospective study with PCBs in small vessel de novo lesions in unselected patients. Rates of TLR and MACE were low, suggesting the use of PCBs may be an attractive alternative treatment option to drug eluting stents in small vessels.